Site Search

>> Advanced Search

Free Newsletter

  Email address:
   

>> Preview...
In the News

Greg Scott joined Foley's Eye on China web conference.
>> More information…

MicuRx Files IND in China for New Antibiotic

publication date: Mar 16, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
MicuRx Pharmaceuticals filed an Investigational New Drug (IND) application with the SFDA for MRX-I, its most-advanced antibiotic drug candidate. MRX-I, an orally-administered oxazolidinone, targets drug resistant infections. MicuRx is headquarterd in the San Francisco area, but it has a 10,000 square foot laboratory in Shanghai’s Zhangjiang High-Tech Park. More details...



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

 

 
   
  Subscribe 
Forgot password?
>> Login help...
ChinaBio® Events
Munich, Germany
November 14, 2010
Suzhou, China
November 17-18, 2010
>>More details...
 
Partner Events

BioPharm America™ 2010
Boston, MA, USA
September 15–17, 2010
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners